S&P 500   4,567.00 (-1.90%)
DOW   34,483.72 (-1.86%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
S&P 500   4,567.00 (-1.90%)
DOW   34,483.72 (-1.86%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
S&P 500   4,567.00 (-1.90%)
DOW   34,483.72 (-1.86%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
S&P 500   4,567.00 (-1.90%)
DOW   34,483.72 (-1.86%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
OTCMKTS:DOCRF

CloudMD Software & Services Stock Forecast, Price & News

$0.99
-0.06 (-5.69%)
(As of 11/30/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.96
▼
$1.10
50-Day Range
$0.96
▼
$1.33
52-Week Range
$0.93
▼
$2.56
Volume
195,250 shs
Average Volume
228,585 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive DOCRF News and Ratings via Email

Sign-up to receive the latest news and ratings for CloudMD Software & Services and its competitors with MarketBeat's FREE daily newsletter.


CloudMD Software & Services logo

About CloudMD Software & Services

CloudMD Software & Services, Inc. operates as an investment company with interests in healthcare and rehabilitation services. It operates through Healthcare Industry segment. The company was founded on September 19, 2013 and is headquartered in Vancouver, Canada.

Headlines

Sun Life Partners with CloudMD to Expand Mental Health Coach To All Group Benefits Clients
November 29, 2021 |  finance.yahoo.com
Here's what to expect from CloudMD Software Services's earnings report
November 28, 2021 |  markets.businessinsider.com
CloudMD Software & Services (OTCMKTS:DOCRF) Price Target Lowered to C$3.00 at Canaccord Genuity
November 16, 2021 |  americanbankingnews.com
CloudMD to Acquire MindBeacon, One of North America's Leading Clinically-Validated iCBT Solutions
November 15, 2021 |  finance.yahoo.com
CloudMD Announces Results of the Annual General & Special Meeting
November 9, 2021 |  finance.yahoo.com
CloudMD Announces Preliminary Q3 2021 Financial Results
November 9, 2021 |  finance.yahoo.com
CloudMD Partners with Apotex Latinoamérica to Drive Expansion of Health Educational Resources Across the Region
November 3, 2021 |  finance.yahoo.com
CloudMD Receives U.S. Patent Approval for its Proprietary Real Time Intervention Platform (RTIP)
October 27, 2021 |  finance.yahoo.com
CloudMD Announces Closing of First Tranche of its Brokered Financing Led By Gravitas Securities
October 27, 2021 |  finance.yahoo.com
CloudMD Adds Comprehensive Health and Wellness Coaching to Proprietary Integrated Health Services Platform
October 13, 2021 |  finance.yahoo.com
CloudMD Adopts Advance Notice Policy
October 6, 2021 |  finance.yahoo.com
Growing Demand for Medical Diagnostic Imaging Creating $45 Billion Opportunity
September 28, 2021 |  baystreet.ca
CloudMD Reports Record Revenue of $15.7 Million in Second Quarter 2021; 9% Quarter Over Quarter Organic Growth
August 25, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Health Information Services
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:DOCRF
Previous Symbol
CUSIP
N/A
CIK
N/A
Web
www.cloudMD.ca
Phone
(778) 370-1413
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Price-To-Earnings

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable

MarketRank™

Overall MarketRank™

1.70 out of 5 stars

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












CloudMD Software & Services (OTCMKTS:DOCRF) Frequently Asked Questions

Is CloudMD Software & Services a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CloudMD Software & Services in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CloudMD Software & Services stock.
View analyst ratings for CloudMD Software & Services or view top-rated stocks.

What price target have analysts set for DOCRF?

3 Wall Street analysts have issued 12-month target prices for CloudMD Software & Services' shares. Their forecasts range from $3.00 to $5.00. On average, they expect CloudMD Software & Services' share price to reach $4.00 in the next year. This suggests a possible upside of 302.4% from the stock's current price.
View analysts' price targets for CloudMD Software & Services or view top-rated stocks among Wall Street analysts.

Who are CloudMD Software & Services' key executives?

CloudMD Software & Services' management team includes the following people:
  • Essam Hamza, Chief Executive Officer & Director
  • Karen Adams, President & Chief Health Innovation Officer
  • Kanchan Thindal, Chief Operating Officer & Secretary
  • Daniel Lee, Chief Financial Officer
  • David Ostrow, Chief Medical Officer

What is CloudMD Software & Services' stock symbol?

CloudMD Software & Services trades on the OTCMKTS under the ticker symbol "DOCRF."

How do I buy shares of CloudMD Software & Services?

Shares of DOCRF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CloudMD Software & Services' stock price today?

One share of DOCRF stock can currently be purchased for approximately $0.99.

What is CloudMD Software & Services' official website?

The official website for CloudMD Software & Services is www.cloudMD.ca.

Where are CloudMD Software & Services' headquarters?

CloudMD Software & Services is headquartered at 789 West Pender Street, Vancouver, BC V6C.

How can I contact CloudMD Software & Services?

CloudMD Software & Services' mailing address is 789 West Pender Street, Vancouver, BC V6C. The company can be reached via phone at (778) 370-1413.


This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.